Education
About Us
Working with TipRanks
Follow Us
Coya Therapeutics, Inc. (COYA)
NASDAQ:COYA
Total Valuation
Coya Therapeutics, Inc. has a market cap or net worth of . The enterprise value is $57.39M.
Market Cap
Enterprise Value$57.39M
Share Statistics
Coya Therapeutics, Inc. has 16.72M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding16.72M
Owened by Insiders23.00%
Owened by Instutions18.96%
Financial Efficiency
Coya Therapeutics, Inc.’s return on equity (ROE) is >-0.01 and return on invested capital (ROIC) is -44.73%.
Return on Equity (ROE)-0.04%
Return on Assets (ROA)-0.03%
Return on Invested Capital (ROIC)-44.73%
Return on Capital Employed (ROCE)-42.57%
Revenue Per Employee$444,257,625
Profits Per Employee-$1,860,098.375
Employee Count8
Asset Turnover0.08
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Coya Therapeutics, Inc. is -5.87. Coya Therapeutics, Inc.’s PEG ratio is -0.24.
PE Ratio-5.87
PS Ratio0.02
PB Ratio<0.01
Price to Fair Value<0.01
Price to FCF>-0.01
Price to Operating Cash Flow>-0.01
PEG Ratio-0.24
Income Statement
In the last 12 months, Coya Therapeutics, Inc. had revenue of $3.55B and earned -$14.88M in profits. Earnings per share was -$0.98.
Revenue$3.55B
Gross Profit$3.55B
Operating Income-$17.25B
Pretax Income-$14.16B
Net Income-$14.88M
EBITDA-17.22M
Earnings Per Share (EPS)-0.98
Cash Flow
In the last 12 months, operating cash flow was -$10.29M and capital expenditures -$50.00K, giving a free cash flow of -$10.29M billion.
Operating Cash Flow-$10.29M
Free Cash Flow-$10.29M
Free Cash Flow per Share-$0.62
Dividends & Yields
Coya Therapeutics, Inc. pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield-11783.03%
Earnings Yield-17.04%
Stock Price Statistics
Beta1.10
52-Week Price Change-38.23%
50-Day Moving Average6.39
200-Day Moving Average6.44
Relative Strength Index (RSI)48.48
Average Volume (3m)96.59K
Important Dates
Coya Therapeutics, Inc. upcoming earnings date is May 8, 2025, Before Open.
Last Earnings DateMar 18, 2025
Next Earnings DateMay 8, 2025
Ex-Dividend Date―
Financial Position
Coya Therapeutics, Inc. as a current ratio of 11.59, with Debt / Equity ratio of 0.00
Current Ratio11.59
Quick Ratio11.59
Debt to Market Cap0.00
Net Debt to EBITDA2.23
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Coya Therapeutics, Inc. has paid $720.29M in taxes.
Income Tax$720.29M
Effective Tax Rate-5.09%
Enterprise Valuation
Coya Therapeutics, Inc. EV to EBITDA ratio is -2.84, with an EV/FCF ratio of >-0.01.
EV to Sales0.01
EV to EBITDA-2.84
EV to Free Cash Flow>-0.01
EV to Operating Cash Flow>-0.01
Balance Sheet
Coya Therapeutics, Inc. has $38.34M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$38.34M billion.
Cash & Marketable Securities$38.34M
Total Debt$0.00
Net Cash-$38.34M
Net Cash Per Share-$2.29
Tangible Book Value Per Share$2.60K
Margins
Gross margin is 100.00%, with operating margin of -485.35%, and net profit margin of -0.42%.
Gross Margin100.00%
Operating Margin-485.35%
Pretax Margin-398.43%
Net Profit Margin-0.42%
EBITDA Margin-0.48%
EBIT Margin-0.49%
Analyst Forecast
The average price target for Coya Therapeutics, Inc. is $15.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$15.00
Price Target Upside190.14%
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast-40.79%
EPS Growth Forecast-16.57%